跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,080 条关于
“Insulin Glargine U100”
全部
10,080
临床试验
8,111
药物
733
机构
9
资讯
1,227
5个月前
Gan & Lee's Once-Weekly Insulin GZR4 Demonstrates Superior Efficacy in Phase 3 Trials
去年
European Study Shows Biosimilar Competition Drives 21.6% Reduction in Insulin Glargine Prices
2年前
Lilly's Once-Weekly Insulin Efsitora Shows Promise in Phase 3 Diabetes Trials
11个月前
Biocon Biologics and Civica Expand Partnership to Launch Private-Label Insulin Glargine in US Market
3年前
Insulin Glargine and Liraglutide Show Superior Performance in Large Type 2 Diabetes Comparative Trial
8个月前
Sandoz Secures European Approval for Ondibta Insulin Glargine Biosimilar, Targeting 66 Million European Diabetes Patients
4个月前
Sunshine Lake Pharma Becomes First Chinese Company to Secure FDA Approval for Insulin Glargine in US Market
2个月前
Trial Supports Glargine Use in Resource-Limited Type 1 Diabetes Care, With Benefits Emerging at 12 Months
8个月前
CivicaScript Launches Low-Cost Insulin Biosimilar and Ustekinumab Alternative in US Market
去年
Lilly's Once-Weekly Insulin Efsitora Alfa Achieves Non-Inferiority in Phase 3 Trials, Reducing Injection Burden by 300 Doses Annually
第 1 页,共 123 页
上一页
下一页